Experience
Valeant Pharmaceuticals Int’l, Inc. v. Mylan Pharmaceuticals, Inc.
Valeant; Salix; Progenics
Mylan Pharmaceuticals, Inc.
Represented Valeant, Salix, and Progenics in Hatch-Waxman patent infringement litigation concerning multiple ANDAs for generic subcutaneous versions of Relistor®. The District of New Jersey granted summary judgment in favor of Valeant, Salix and Progenics on U.S. Patent No. 8,552,025 covering Subcutaneous Relistor® through 2024.
Valeant; Salix; Progenics v. Mylan Pharmaceuticals, Inc., 2:15-cv-08180, 2:17-cv-06714, D.N.J., Judges Chesler, Waldor
